{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:51Z","timestamp":1791925671175,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.biocel.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T14:38:36Z","timestamp":1466260716000},"page":"356-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"PB","title":["Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases"],"prefix":"10.1016","volume":"81","author":[{"given":"Massimiliano","family":"Castellazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Trentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Valacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Bonaccorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Cavicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Passaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cervellati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2016.06.008_bib0005","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biocel.2016.06.008_bib0010","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","article-title":"Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants","volume":"26","author":"Aviram","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biocel.2016.06.008_bib0015","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biocel.2016.06.008_bib0020","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.biocel.2016.06.008_bib0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2012.5027","article-title":"Amyloid \u03b2-peptide (1\u201342)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression","volume":"19","author":"Butterfield","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biocel.2016.06.008_bib0030","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3109\/09513590.2011.579653","article-title":"17\u03b2-estradiol levels and oxidative balance in a population of pre-, peri-, and post-menopausal women","volume":"27","author":"Cervellati","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.biocel.2016.06.008_bib0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1567205011310040003","article-title":"Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer\u2019s disease","volume":"10","author":"Cervellati","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.biocel.2016.06.008_bib0040","doi-asserted-by":"crossref","first-page":"309507","DOI":"10.1155\/2014\/309507","article-title":"Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment","volume":"2014","author":"Cervellati","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biocel.2016.06.008_bib0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jns.2013.11.041","article-title":"Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer\u2019s Disease or Vascular Dementia","volume":"337","author":"Cervellati","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biocel.2016.06.008_bib0050","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1515\/cclm-2014-0803","article-title":"PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer\u2019s disease or vascular dementia","volume":"53","author":"Cervellati","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.biocel.2016.06.008_bib0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jnc.13240","article-title":"Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: a pilot study","volume":"135","author":"Cervellati","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biocel.2016.06.008_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/jim-2015-000017","article-title":"Oxidative challenge in Alzheimer\u2019s disease: state of knowledge and future needs","volume":"64","author":"Cervellati","year":"2016","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.biocel.2016.06.008_bib0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1373\/clinchem.2005.063412","article-title":"Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate","volume":"52","author":"Charlton-Menys","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biocel.2016.06.008_bib0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/ars.2013.5258","article-title":"The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension","volume":"20","author":"Crowley","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biocel.2016.06.008_bib0075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","article-title":"Biomarkers of oxidative damage in human disease","volume":"52","author":"Dalle-Donne","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biocel.2016.06.008_bib0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2002.tb04802.x","article-title":"Paraoxonase 1 activity: a new vascular marker of dementia?","volume":"977","author":"Dantoine","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biocel.2016.06.008_bib0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer\u2019s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"De La Torre","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biocel.2016.06.008_bib0090","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3758\/BF03195907","article-title":"Comparisons, mental models, and the action effect in judgments of regret","volume":"34","author":"Feeney","year":"2006","journal-title":"Mem. Cognit."},{"key":"10.1016\/j.biocel.2016.06.008_bib0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jns.2011.09.004","article-title":"Peroxidation of lipoproteins in multiple sclerosis","volume":"311","author":"Ferretti","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biocel.2016.06.008_bib0100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1191\/1352458505ms1240oa","article-title":"Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity","volume":"11","author":"Ferretti","year":"2005","journal-title":"Mult. Scler."},{"key":"10.1016\/j.biocel.2016.06.008_bib0105","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/brain\/aws012","article-title":"NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.biocel.2016.06.008_bib0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0090-9556(25)07065-5","article-title":"Purification of human serum paraoxonase\/arylesterase. Evidence for one esterase catalyzing both activities","volume":"19","author":"Gan","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biocel.2016.06.008_bib0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biocel.2016.06.008_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2008.08.035","article-title":"Elevated myeloperoxidase activity in white matter in multiple sclerosis","volume":"444","author":"Gray","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biocel.2016.06.008_bib0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11010-014-2274-1","article-title":"Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening","volume":"400","author":"Guan","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biocel.2016.06.008_bib0130","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awr128","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.biocel.2016.06.008_bib0135","doi-asserted-by":"crossref","first-page":"725370","DOI":"10.1155\/2015\/725370","article-title":"Inflammation, iron, energy failure, and oxidative stress in the pathogenesis of multiple sclerosis","volume":"2015","author":"Haider","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biocel.2016.06.008_bib0140","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biocel.2016.06.008_bib0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-4933-6-13","article-title":"Pathophysiology of vascular dementia","volume":"6","author":"Iemolo","year":"2009","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.biocel.2016.06.008_bib0150","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1515\/CCLM.2006.207","article-title":"A long and winding road: defining the biological role and clinical importance of paraoxonases","volume":"44","author":"James","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.biocel.2016.06.008_bib0155","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","article-title":"Alzheimer\u2019s disease and vascular dementia in developing countries: prevalence, management, and risk factors","volume":"7","author":"Kalaria","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biocel.2016.06.008_bib0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinbiochem.2014.09.023","article-title":"Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis","volume":"48","author":"Karl\u00edk","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biocel.2016.06.008_bib0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/cbic.200500334","article-title":"Chromogenic and fluorogenic assays for the lactonase activity of serum paraoxonases","volume":"7","author":"Khersonsky","year":"2006","journal-title":"Chembiochem"},{"key":"10.1016\/j.biocel.2016.06.008_bib0170","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jocn.2012.09.020","article-title":"Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis","volume":"20","author":"Kirbas","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.biocel.2016.06.008_bib0175","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2016.06.008_bib0180","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2015.09.018","article-title":"Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions","volume":"1862","author":"Lassmann","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biocel.2016.06.008_bib0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.envint.2013.03.004","article-title":"Functional paraoxonase 1 variants modify the risk of Parkinson\u2019s disease due to organophosphate exposure","volume":"56","author":"Lee","year":"2013","journal-title":"Environ. Int."},{"key":"10.1016\/j.biocel.2016.06.008_bib0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/157015911796557911","article-title":"Multiple sclerosis: pathogenesis and treatment","volume":"9","author":"Loma","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biocel.2016.06.008_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","article-title":"Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles","volume":"567","author":"Mackness","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.biocel.2016.06.008_bib0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12017-009-8095-9","article-title":"Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis","volume":"12","author":"Mart\u00ednez","year":"2010","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.biocel.2016.06.008_bib0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neulet.2006.12.044","article-title":"Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients","volume":"414","author":"Mattsson","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biocel.2016.06.008_bib0210","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2016.06.008_bib0215","doi-asserted-by":"crossref","first-page":"572491","DOI":"10.1155\/2014\/572491","article-title":"Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases","volume":"2014","author":"Miller","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biocel.2016.06.008_bib0220","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.clinbiochem.2011.04.010","article-title":"Lack of association between paraoxonase 1 Q192R polymorphism and multiple sclerosis in relapse phase: a case-control study","volume":"44","author":"Moghtaderi","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biocel.2016.06.008_bib0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1385\/JMN:16:2-3:195","article-title":"Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro","volume":"16","author":"Moore","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biocel.2016.06.008_bib0230","doi-asserted-by":"crossref","first-page":"708659","DOI":"10.1155\/2013\/708659","article-title":"Immunology and oxidative stress in multiple sclerosis: clinical and basic approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.biocel.2016.06.008_bib0235","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neulet.2012.06.071","article-title":"Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer\u2019s disease: a meta-analysis","volume":"523","author":"Pi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biocel.2016.06.008_bib0240","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biocel.2016.06.008_bib0245","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9","article-title":"Increased 8,12-iso-iPF2alpha-VI in Alzheimer\u2019s disease: correlation of a noninvasive index of lipid peroxidation with disease severity","volume":"48","author":"Pratic\u00f2","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biocel.2016.06.008_bib0250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2016.06.008_bib0255","doi-asserted-by":"crossref","first-page":"e57820","DOI":"10.1371\/journal.pone.0057820","article-title":"Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression","volume":"8","author":"Romme Christensen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2016.06.008_bib0260","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1074\/jbc.M512595200","article-title":"The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux","volume":"281","author":"Rosenblat","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biocel.2016.06.008_bib0265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2005.08.026","article-title":"Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes","volume":"187","author":"Rosenblat","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biocel.2016.06.008_bib0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/gm338","article-title":"Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases","volume":"4","author":"Schwarz","year":"2012","journal-title":"Genome Med."},{"key":"10.1016\/j.biocel.2016.06.008_bib0275","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/ene.12074","article-title":"Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities","volume":"20","author":"Shenhar-Tsarfaty","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.biocel.2016.06.008_bib0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tem.2013.10.003","article-title":"What are lipoproteins doing in the brain?","volume":"25","author":"Wang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biocel.2016.06.008_bib0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2009.02.317","article-title":"Paraoxonase activity and dementia","volume":"283","author":"Wehr","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biocel.2016.06.008_bib0290","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/cclm.2011.792","article-title":"Urinary 8-hydroxy-2\u2032-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer's disease","volume":"50","author":"Zengi","year":"2012","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272516301480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272516301480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:04:30Z","timestamp":1761203070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272516301480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":58,"alternative-id":["S1357272516301480"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2016.06.008","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}